Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Seattle, Washington 98108


Purpose:

This study examines the use of insulin-sensitizing compounds, as therapeutic agents for cognitive impairment in Alzheimer's disease.


Criteria:

Men and women with mild Alzheimer's Disease without serious medical or psychiatric comorbid conditions.


NCT ID:

NCT00018382


Primary Contact:

Steven Kahn, M.D.


Backup Contact:

N/A


Location Contact:

Seattle, Washington 98108
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: September 20, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.